Merdica Private Limited

Tofizid-5, with Tofacitinib 5 mg as its active ingredient, is a medication primarily used to treat various inflammatory conditions. It is classified as a Janus kinase (JAK) inhibitor and is commonly prescribed for moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. The drug works by modulating the immune system to reduce inflammation, which helps alleviate pain, tenderness, and swelling in the joints and can slow the progression of bone and joint damage. It is important to follow the prescribed dosage and administration guidelines provided by healthcare professionals.